Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Summary 
Raghuram Selvaraju is Chairman of RELIEF THERAPEUTICS Holding AG and Managing Director & Senior Healthcare Analyst at H. C. Wainwright & Co. LLC. Dr. Selvaraju is also Managing Director-Equity Research at H C Wainwright & Co.

In his past career he held the position of Analyst at Serono Pharmaceutical Research Institute, Managing Director & Associate Analyst at Rodman & Renshaw LLC (Old), Senior Biotechnology Analyst at Morgan Joseph TriArtisan LLC, MD & Head-Health Care Equity Research at Aegis Capital Corp., Senior Research Analyst at Noble Capital Markets, Inc., Senior Analyst at Hapoalim Securities USA, Inc. and Managing Director & Senior Healthcare Analyst at MLV & Co. LLC.

Dr. Selvaraju received an undergraduate degree from Carnegie Mellon University, a doctorate and a graduate degree from the University of Geneva and an MBA from Cornell University.


Current positions of Raghuram Selvaraju 
NameTitle Since
Relief Therapeutics Holding AG
(Biotechnology & Medical Research)
Chairman 2016
H C Wainwright & Co. Managing Director-Equity Research -
H. C. Wainwright & Co. LLC Managing Director & Senior Healthcare Analyst 2015


Raghuram Selvaraju: Personal Network 
Most Read News 
01/13Investor Peltz, corporate doctor, pushes Disney to take bitter pill
RE
01/25Musk says China rivals 'work hardest, smartest'
RE
01/13Musk bets big on beating shareholders at 'funding secured' trial
RE
01/26LVMH's Arnault brushes off succession question
RE
01/19Ark's Wood remains bullish on Tesla, says oil stock rally 'defying logic'
RE
07:41aPrada appoints former Luxottica chief Guerra as new CEO
RE
01/19JPMorgan CEO Dimon sees interest rates going beyond 5% - CNBC
RE
01/23Musk to return to stand in fraud trial over 2018 Tesla tweet
RE
01/19Sacked GM workers in India sue company, CEO Barra for unpaid compensation
RE
01/20Musk expected to take stand as trial resumes over Tesla tweet
RE
More news


© 2023 People and Ownership :   
Raghuram Selvaraju : Connections